Searched for
BIOGEN COS
Warren Buffett's Berkshire pares drug holdings, sheds Axalta, BiogenIn the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squ...- US FDA okays Biogen Alzheimer’s drugUS regulators on Monday approved Biogen’s aducanumab as the first treatment to address an underlying cause of Alzheimer’s disease despite c...
- Biogen for inlicensing deal with Indian cosUS-based biotech company Biogen Idec, is looking for partnerships across the pharma value chain, including in-licensing of new experimental...
- Load More